The global proton therapy market is anticipated to witness a compound annual growth rate of 4.03% during the forecast period to reach a total market size of US$2.305 billion by 2023, increasing from US$1.819 billion in 2017.
The global proton therapy market growth is expected to be driven by a surge in demand from cancer therapy centres. Higher prevalence of cancer has encouraged more clinical research, better clinical understanding and higher patient awareness, which in turn will drive the demand for proton therapy Proton therapy is a highly precise radiation delivering therapeutic procedure for the treatment of cancer and this will boost the growth of the market. The proton therapy market is expected to witness much higher growth on account of rising number of potential candidates for proton therapy. However, High cost of treatment, lack of investment and overlooking of market potential will hamper the market growth over the next year.
This research study examines the current market trends related to the demand, supply, and sales, in addition to the recent developments. Major drivers, restraints, and opportunities have been covered to provide an exhaustive picture of the market. The analysis presents in-depth information regarding the development, trends, and industry policies and regulations implemented in each of the geographical regions. Further, the overall regulatory framework of the market has been exhaustively covered to offer stakeholders a better understanding of the key factors affecting the overall market environment.
Identification of key industry players in the industry and their revenue contribution to the overall business or relevant segment aligned to the study have been covered as a part of competitive intelligence done through extensive secondary research. Various studies and data published by industry associations, analyst reports, investor presentations, press releases and journals among others have been taken into consideration while conducting the secondary research. Both bottom-up and top-down approaches have been utilized to determine the market size of the overall market and key segments. The values obtained are correlated with the primary inputs of the key stakeholders in the proximity sensors value chain. The last step involves complete market engineering which includes analyzing the data from different sources and existing proprietary datasets while using various data triangulation methods for market breakdown and forecasting.
Market intelligence is presented in the form of analysis, charts, and graphics to help the clients in gaining faster and efficient understanding of the market.
Major industry players profiled as part of the report are Mevion Medical Systems, ProNova Solutions, LLC, Proton International, Optivus Proton Therapy, Inc., and Advanced Oncotherapy Plc among others.
|Market size value in 2017||US$1.819 billion|
|Market size value in 2023||US$2.305 billion|
|Growth Rate||CAGR of 4.03% from 2017 to 2023|
|Forecast Unit (Value)||USD Billion|
|Segments covered||Application, And Geography|
|Regions covered||North America, South America, Europe, Middle East and Africa, Asia Pacific|
|Companies covered||Hitachi Ltd., Ion Beam Applications SA, Mevion Medical Systems, Mitsubishi Electric Corporation, ProNova Solutions, LLC, ProTon International, Sumitomo Heavy Industries Ltd., Varian Medical Systems, Optivus Proton Therapy, Inc., Advanced Oncotherapy plc, Varian Medical Systems, Inc.|
|Customization scope||Free report customization with purchase|
The Proton Therapy market has been analyzed through following segments:
Middle East and Africa
United Arab Emirates
Frequently Asked Questions (FAQs)
Ion Beam Applications SA
Mevion Medical Systems
Mitsubishi Electric Corporation
ProNova Solutions, LLC
Sumitomo Heavy Industries Ltd.
Varian Medical Systems
Optivus Proton Therapy, Inc.
Advanced Oncotherapy plc
Varian Medical Systems, Inc.
All our studies come with 2 months of analyst support.
We are in compliance with the global privacy laws.